Superior Effectiveness and Estimated Public Health Impact of Cell- Versus Egg-Based Influenza Vaccines in Children and Adults During the US 2023-2024 Season [0.03%]
细胞基流感疫苗与鸡胚流感疫苗在儿童和成人中的优越有效性和对公共卫生活的影响：美国2023-2024年度的估计数据
Alicia N Stein,Anusorn Thanataveerat,Kimberly McDermott et al.
Alicia N Stein et al.
Introduction: The aim of this study was to assess the relative vaccine effectiveness (rVE) of cell-based versus egg-based quadrivalent influenza vaccines (QIVc versus QIVe) in preventing test-confirmed influenza during th...
Rate and Predictors of Urine Culture Positivity Following Single-Dose Antibiotic Administration: a Prospective Single-Center Study [0.03%]
单剂量抗生素使用后阳性尿培养的发生率及其影响因素：一项前瞻性单中心研究
Neta Sror,Gil Bornstein,Lior Golan et al.
Neta Sror et al.
Introduction: International guidelines advocate obtaining urine cultures prior to antibiotic administration in hospitalized patients with suspected urinary tract infection (UTI). However, adherence remains suboptimal. The...
Correction: Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections [0.03%]
关于埃拉韦治疗马尔蒂摩菌感染患者临床结局的更正公告
Mohammed Al Musawa,Ashlan J Kunz Coyne,Sara Alosaimy et al.
Mohammed Al Musawa et al.
Published Erratum
Infectious diseases and therapy. 2025 Sep 29. DOI:10.1007/s40121-025-01242-y 2025
Two Decades of Living with Echinococcus multilocularis: A Clinical Epidemiology Study on Human Alveolar Echinococcosis in Hungary [0.03%]
匈牙利人患泡状棘球蚴病的临床流行病学研究——与多房棘球绦虫共存二十年
Eszter Csulak,Damján Pekli,Ágnes Csivincsik et al.
Eszter Csulak et al.
Introduction: The zoonotic parasite Echinococcus multilocularis emerged in Hungary in the early 2000s. During the next two decades, it continuously spread in both wildlife and the human population. The first comprehensive...
Preferences of Dutch Parents and Expectant Parents for Respiratory Syncytial Virus Prevention Strategies: A Discrete Choice Experiment [0.03%]
荷兰父母和待产家长对呼吸道合胞病毒预防策略的偏好：离散选择实验
Annefleur C Langedijk,Floris van den Dungen,Lisette Harteveld et al.
Annefleur C Langedijk et al.
Introduction: Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infection in infants. This study examined the preferences of Dutch parents and expectant parents for two RSV prevention...
Temporal Dynamics of SARS-CoV-2 Detection in Household Contacts: Divergences Between Time to First Positive Test, Symptom Onset, and Maximum Viral Load [0.03%]
家庭接触者中SARS-CoV-2检测的动态变化：首次阳性测试时间、症状出现时间和最大病毒载量之间的差异
Annemarie Berger,Ana M Groh,Damian Diaz et al.
Annemarie Berger et al.
Introduction: Understanding the temporal dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is crucial for optimizing diagnostic strategies. This prospective cohort study aimed to quantify ...
Lung Health and Respiratory Syncytial Virus: Podcast of a Patient-Physician Discussion Based on Insights from a Patient Advisory Board Meeting [0.03%]
基于患者咨询委员会会议见解的患者与医师会谈的 podcast：有关呼吸合胞病毒与肺健康的讨论
Bela Vatsa,Lisa McNeil,Peter Deussen et al.
Bela Vatsa et al.
An advisory board meeting was held with five participants living with chronic respiratory conditions or having experienced a severe episode of respiratory syncytial virus (RSV) infection, to understand the challenges faced by such individua...
Optimizing Polymyxin B Therapy in Critical Care: Pharmacokinetic Insights and Clinical Outcomes in a Retrospective Cohort Study [0.03%]
危重症患者多黏菌素B治疗优化：一项回顾性队列研究中的药代动力学见解和临床结局
Qingyun Peng,Qing Li,Mengru Xiong et al.
Qingyun Peng et al.
Introduction: Carbapenem-resistant Gram-negative bacteria pose significant global health threats due to high infection rates and limited treatment options. Polymyxin B (PMB) has reemerged as a last-line therapy against th...
Antiviral Combination Treatment for COVID-19 in Immunocompromised Patients: Towards Defining Its Place in Therapy [0.03%]
免疫缺陷患者的新冠抗病毒联合治疗：定义其在治疗中的地位
Chiara Sepulcri,Claudia Bartalucci,Elisa Balletto et al.
Chiara Sepulcri et al.
Introduction: Antiviral combinations have been successfully used to treat COVID-19 in immunocompromised patients, especially those with prolonged viral shedding or relapses. This study assessed outcomes of antiviral combi...
The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025? [0.03%]
艾滋病治疗中蛋白酶抑制剂的作用：谁还需要它们(直到2025年)?
Abiu Sempere,Rodrigo Alonso,Leire Berrocal et al.
Abiu Sempere et al.
Introduction: Protease inhibitors (PIs) remain an effective antiretroviral therapy (ART) option for people with human immunodeficiency virus (HIV) (PWH), particularly in complex clinical and virological scenarios. Howeve...